Brain-Penetrating Peptide Shuttles across the Blood–Brain Barrier and Extracellular-like Space
Bioconjugate Chemistry · 20.12.2023 · 34 (12) · 2319-2336
DOI: 10.1021/acs.bioconjchem.3c00446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 12.12.2023. Verfasst von Xiujuan Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, United States. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Brain. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 105 Literaturangaben. Gefördert von: National Heart, Lung, and Blood Institute, University of Texas at Austin, Pharmaceutical Research and Manufacturers of America Foundation.
Abstract (Originalsprache)
Systemic delivery of therapeutics into the brain is greatly impaired by multiple biological barriers─the blood-brain barrier (BBB) and the extracellular matrix (ECM) of the extracellular space. To address this problem, we developed a combinatorial approach to identify peptides that can shuttle and transport across both barriers. A cysteine-constrained heptapeptide M13 phage display library was iteratively panned against an established BBB model for three rounds to select for peptides that can transport across the barrier. Using next-generation DNA sequencing and in silico analysis, we identified peptides that were selectively enriched from successive rounds of panning for functional validation in vitro and in vivo. Select peptide-presenting phages exhibited efficient shuttling across the in vitro BBB model. Two clones, Pep-3 and Pep-9, exhibited higher specificity and efficiency of transcytosis than controls. We confirmed that peptides Pep-3 and Pep-9 demonstrated better diffusive transport through the extracellular matrix than gold standard nona-arginine and clinically trialed angiopep-2 peptides. In in vivo studies, we demonstrated that systemically administered Pep-3 and Pep-9 peptide-presenting phages penetrate the BBB and distribute into the brain parenchyma. In addition, free peptides Pep-3 and Pep-9 achieved higher accumulation in the brain than free angiopep-2 and may exhibit brain targeting. In summary, these in vitro and in vivo studies highlight that combinatorial phage display with a designed selection strategy can identify peptides as promising carriers, which are able to overcome the multiple biological barriers of the brain and shuttle different-sized molecules from small fluorophores to large macromolecules for improved delivery into the brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, United States.
- Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, United States.
ORCID-Profile: Jasmim Leal, Debadyuti Ghosh
Förderung
- National Heart, Lung, and Blood Institute
- University of Texas at Austin
- Pharmaceutical Research and Manufacturers of America Foundation
Zitieren
APA
Peng, X., Liu, X., Kim, J. Y., Nguyen, A., Leal, J., & Ghosh, D. (2023). Brain-Penetrating Peptide Shuttles across the Blood–Brain Barrier and Extracellular-like Space. Bioconjugate Chemistry, 34(12), 2319-2336. https://doi.org/10.1021/acs.bioconjchem.3c00446
Vancouver
Peng X, Liu X, Kim JY, Nguyen A, Leal J, Ghosh D. Brain-Penetrating Peptide Shuttles across the Blood–Brain Barrier and Extracellular-like Space. Bioconjugate Chemistry. 2023;34(12):2319-2336. doi:10.1021/acs.bioconjchem.3c00446
BibTeX
@article{Peng2023,
author = {Peng, Xiujuan and Liu, Xinquan and Kim, Jae You and Nguyen, Alex and Leal, Jasmim and Ghosh, Debadyuti},
title = {Brain-Penetrating Peptide Shuttles across the Blood–Brain Barrier and Extracellular-like Space},
journal = {Bioconjugate Chemistry},
year = {2023},
volume = {34},
number = {12},
pages = {2319--2336},
doi = {10.1021/acs.bioconjchem.3c00446}
}
EUVIMED